middl
east
respiratori
syndrom
mer
highli
lethal
respiratori
diseas
caus
singlestrand
positivesens
rna
betacoronaviru
merscoronaviru
merscov
sever
mer
rang
asymptomat
mild
diseas
acut
respiratori
distress
syndrom
lead
death
clinic
featur
includ
fever
cough
short
breath
multiorgan
failur
result
death
especi
individu
underli
comorbid
diabet
renal
failur
sinc
merscov
first
isol
patient
fatal
respiratori
diseas
kingdom
saudi
arabia
world
health
organ
notifi
laboratori
confirm
case
merscov
infect
death
april
although
mer
occur
middl
east
includ
kingdom
saudi
arabia
unit
arab
emir
patient
mer
also
report
mer
nonendem
region
europ
unit
state
asia
import
case
middl
east
addit
larg
outbreak
south
korea
suggest
mer
remain
seriou
threat
global
public
health
vaccin
expect
efficaci
strategi
prevent
individu
anim
suffer
merscov
infect
date
variou
kind
candid
vaccin
mer
develop
includ
live
attenu
subunit
dna
primeboost
recombin
vector
vaccin
howev
approv
vaccin
specif
treatment
mer
current
avail
merscov
spike
glycoprotein
compris
subunit
region
subunit
merscov
respons
bind
host
cell
express
viral
receptor
dipeptidyl
peptidas
receptorbind
domain
rbd
vaccin
develop
previou
studi
show
protein
could
serv
domin
target
virusspecif
neutral
antibodi
vna
fact
protein
use
antigen
sever
merscov
vaccin
prepar
exampl
fulllength
protein
truncat
glycoprotein
incorpor
sever
vector
vaccin
merscov
subsequ
elicit
vna
follow
inocul
candid
anim
rabi
viral
diseas
caus
rabi
viru
rv
negativesens
singlestrand
rna
viru
rhabdovirida
famili
simpl
genom
organ
encod
five
structur
protein
rabi
human
almost
alway
fatal
upon
appear
clinic
symptom
howev
rabi
vaccineprevent
diseas
rabiesinactiv
vaccin
provid
close
protect
pre
postexposur
prophylaxi
save
million
live
sinc
develop
first
rabi
vaccin
human
estim
peopl
still
die
rabi
annual
case
report
countri
territori
among
variou
anim
mainli
dog
human
therefor
set
goal
elimin
human
death
due
rabi
inactiv
rabi
vaccin
current
avail
worldwid
howev
ideal
strategi
requir
frequent
administr
dose
point
attenu
live
vaccin
repres
promis
attract
altern
elicit
humor
cellular
immun
suggest
frequent
vaccin
need
rv
genom
encod
five
structur
protein
nucleoprotein
n
phosphoprotein
p
matrix
protein
glycoprotein
g
larg
protein
l
pgenedefici
rabi
viru
replicationincompet
rvp
protein
multifunct
protein
serv
stabil
rvl
protein
major
compon
viral
rna
polymeras
similarli
mgenedefici
rv
propag
impair
rvm
protein
particip
bud
process
remain
capabl
express
viral
protein
assembl
propag
special
construct
cell
express
rvp
rvm
protein
respect
howev
infecti
progeni
produc
cell
therefor
virus
consid
candid
develop
safe
effect
attenu
rv
vaccin
human
anim
rv
repres
attract
express
vector
potenti
util
viral
vaccin
vector
base
sever
advantag
vaccin
develop
rv
possess
rel
simpl
modular
genom
organ
render
genet
modif
easier
rel
complex
genom
dna
plusstrand
rna
virus
rv
exhibit
cytoplasm
replic
cycl
suggest
viru
would
affect
genom
host
cell
fullgenom
rv
vector
provid
suffici
capac
insert
larg
foreign
gene
stabli
express
preserv
rv
noncytopath
infect
cell
therebi
allow
sustain
product
insert
gene
extend
period
rv
induc
protect
immun
respons
varieti
mammalian
speci
preexist
vector
immun
rv
prevent
induct
antibodi
foreign
antigen
suggest
rvbase
vaccin
strategi
might
effect
previous
rvvaccin
human
boost
variou
rvvector
vaccin
might
success
base
advantag
sever
bival
vaccin
target
diseas
use
replicationincompet
rv
harbor
foreign
gene
insert
revers
genet
techniqu
develop
studi
develop
bivalentvaccin
candid
merscov
rv
use
vector
evalu
induct
humor
immun
respons
merscov
rv
well
safeti
profil
cell
obtain
jcrb
cell
bank
origin
american
type
cultur
collect
atcc
manassa
va
usa
vero
cell
cell
purchas
atcc
respect
cell
cell
grown
dulbecco
modifi
eagl
medium
dmem
sigmaaldrich
st
loui
mo
usa
supplement
heatinactiv
fetal
bovin
serum
fb
biowest
franc
antibiot
uml
penicillin
streptomycin
thermo
fisher
scientif
waltham
usa
vero
cell
grown
dmem
supplement
heatinactiv
fb
antibiot
cell
line
express
recombin
rvp
protein
bhkp
grown
zeocin
thermo
fisher
scientif
merscov
spike
glycoprotein
compris
subunit
region
subunit
primari
target
vna
protein
cleav
subunit
variou
host
proteas
express
protein
effici
membran
virion
rvg
transmembran
cytoplasm
domain
fuse
protein
cdna
encod
rvg
transmembran
cytoplasm
domain
togeth
amino
acid
ectodomain
rvg
rvtmcd
amplifi
primer
harbor
bsiwi
psti
restrict
enzym
site
end
follow
clone
pgemt
easi
vector
promega
madison
wi
usa
rvtmcd
fragment
digest
insert
bsiwi
psti
site
plasmid
result
cdna
region
correspond
amino
acid
codonoptim
glycoprotein
sino
biolog
beij
china
merscov
access
number
amplifi
insert
plasmid
use
infus
hd
clone
kit
takara
bio
shiga
japan
produc
fig
hepfluri
parent
strain
genbank
appli
human
use
inactiv
rv
due
statu
among
attenu
rv
strain
hepfluri
caus
symptom
adult
mice
kill
suckl
mice
inocul
intracerebr
recombin
hep
viru
rhep
rescu
fulllength
cdna
hepfluri
strain
propag
bhk
cell
rescu
fulllength
cdna
rv
genom
lack
rvp
gene
four
helper
plasmid
phn
php
phg
phl
revers
genet
method
propag
bhkp
cell
describ
previous
addit
rescu
cell
use
revers
genet
method
four
helper
plasmid
follow
propag
bhkp
cell
anim
experi
purifi
concentr
briefli
bhkp
cell
infect
multipl
infect
moi
maintain
hyper
flask
corn
corn
ny
usa
fill
dmem
supplement
fb
antibiot
supernat
collect
day
cultur
medium
replac
day
supernat
filter
use
polyethersulfon
membran
filter
thermo
fisher
scientif
remov
cell
debri
releas
virus
concentr
precipit
polyethylen
glycol
peg
wako
osaka
japan
virion
purifi
ultracentrifug
precipit
min
g
sucros
wako
treat
amicon
merck
corpor
darmstadt
germani
purifi
viru
stock
store
use
bhkp
cell
seed
onto
cultur
plate
follow
day
infect
h
replac
inoculum
fresh
cell
cultur
h
cell
subsequ
fix
wako
min
wash
twice
phosphatebuff
salin
pb
cell
permeabil
triton
min
room
temperatur
wash
pb
three
time
detect
merscov
express
cell
block
pb
contain
fb
h
stain
mous
monoclon
antibodi
mab
merscov
kindli
provid
dr
kazuo
ohnishi
nation
institut
infecti
diseas
niid
h
cell
wash
pb
react
secondari
antibodi
dylight
polyclon
antimous
immunoglobulin
ig
g
hl
vector
laboratori
burlingam
ca
usa
detect
rvn
express
cell
stain
fluorescein
isothiocyan
fitc
label
antirv
mab
fujirebio
tokyo
japan
h
fluoresc
imag
observ
use
confoc
laserscan
microscop
fluoview
olympu
tokyo
japan
titer
newli
gener
determin
focu
assay
bhkp
cell
describ
previous
briefli
bhkp
cell
prepar
plate
previou
day
inocul
viru
solut
dilut
serial
incub
day
thereaft
fix
cell
aceton
room
temperatur
min
stain
fitclabel
antirv
mab
foci
count
fluoresc
microscop
cell
infect
either
incub
h
follow
wash
pb
twice
lysi
centrifug
g
min
sampl
supernat
mix
equal
volum
sampl
buffer
contain
incub
min
sampl
separ
use
precast
gel
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
atto
tokyo
japan
transfer
onto
polyvinyliden
difluorid
membran
place
ibind
western
system
thermo
fisher
scientif
accord
manufactur
instruct
primari
antibodi
use
detect
rvg
antirvg
kindli
provid
dr
nobuyuki
minamoto
gifu
univers
gifu
japan
primari
antibodi
use
detect
merscov
spike
protein
polyclon
antibodi
merscov
spike
protein
sino
biolog
addit
use
polyclon
antibodi
tubulin
medic
biolog
laboratori
nagoya
japan
detect
tubulin
intern
control
secondari
antibodi
detect
rvg
merscov
spike
protein
horseradish
peroxidaseconjug
antimous
antirabbit
igg
hl
thermo
fisher
scientif
respect
incub
secondari
antibodi
h
membran
wash
deioniz
water
stain
supersign
west
femto
thermo
fisher
scientif
visual
use
fujifilm
tokyo
japan
merscov
spike
protein
sino
biolog
use
posit
control
onedayold
icr
suckl
mice
purchas
japan
slc
shizuoka
japan
allow
acclim
day
eight
suckl
mice
place
cage
untreat
mother
cage
randomli
divid
three
group
suckl
mice
inject
rhep
group
includ
two
cage
n
mice
mice
inocul
intracerebr
viru
solut
contain
focusform
unit
ffu
ml
suckl
mice
observ
clinic
sign
week
threeweekold
femal
balbc
mice
purchas
japan
slc
allow
acclim
week
mice
randomli
divid
five
experiment
group
shown
tabl
mice
inocul
intraperiton
viru
solut
contain
ffuml
pb
day
mice
inocul
virus
defin
day
blood
sampl
collect
cardiac
punctur
termin
anesthesia
isofluran
day
mice
euthan
blood
collect
experi
perform
duplic
sera
separ
wholeblood
sampl
centrifug
store
requir
test
sera
heat
min
inactiv
complement
factor
neutral
test
live
merscov
perform
describ
previous
briefli
serial
dilut
serum
sampl
mix
viru
solut
contain
plaqueform
unit
merscov
emc
isol
h
vero
cell
seed
cultur
plate
inocul
serumviru
mixtur
postinfect
cell
fix
formalin
stain
crystal
violet
cytopath
effect
cpe
vero
cell
observ
neutral
titer
determin
highest
dilut
show
least
cpe
inhibit
titer
vna
rv
determin
use
modifi
rapid
fluoresc
focusform
inhibit
test
describ
previous
briefli
heatinactiv
sera
describ
previou
subsect
serial
dilut
sera
ad
well
cell
cultur
plate
sera
mix
equal
volum
hepfluri
viru
solut
contain
focusform
dose
incub
h
suspend
cell
ad
well
cellsml
cell
incub
h
fix
aceton
min
room
temperatur
cell
stain
fitclabel
antirv
antibodi
h
vna
titer
defin
serum
dilut
fluoresc
focu
reduct
infect
cultur
neutral
dose
calcul
accord
method
valu
normal
intern
unit
iu
use
antirv
ig
u
test
logrank
test
use
compar
viral
growth
compar
characterist
fatal
nonfat
mice
curv
respect
nonparametr
test
use
multipl
comparison
vna
titer
pvalu
twosid
p
consid
signific
data
analyz
use
stata
window
statacorp
lp
colleg
station
tx
usa
jmp
softwar
sa
institut
cari
nc
usa
anim
studi
perform
strict
accord
recommend
describ
guidelin
proper
conduct
anim
experi
scienc
council
japan
strict
complianc
anim
husbandri
welfar
regul
anim
experi
review
approv
institut
anim
care
use
committe
niid
approv
no
anim
infect
rv
handl
biosafeti
level
anim
facil
accord
niid
guidelin
mice
inocul
viru
proper
anesthesia
studi
use
human
endpoint
earli
indic
anim
pain
distress
could
use
avoid
limit
suffer
take
action
human
euthanasia
observ
period
monitor
neurolog
symptom
daili
set
human
endpoint
mice
consid
reach
moribund
stage
ie
observ
rabiesassoci
clinic
sign
infect
eg
paralysi
seizur
moribund
mice
euthan
isofluran
immedi
reach
endpoint
criteria
research
staff
special
train
anim
care
treatment
standard
oper
procedur
laboratori
recombin
virus
gener
plasmid
use
revers
genet
techniqu
fig
correct
construct
absenc
mutat
insert
gene
posit
rvn
rvm
confirm
use
sequenc
produc
viral
genom
immunofluoresc
assay
express
merscov
protein
confirm
bhkp
cell
infect
bhkp
cell
infect
wherea
rvnantigenposit
cell
observ
bhkp
cell
fig
moreov
western
blot
analysi
confirm
exist
merscov
protein
bhkp
cell
bhkp
cell
wherea
rvg
protein
detect
bhkp
cell
fig
furthermor
merscov
protein
detect
pegprecipit
purifi
pegprecipit
purifi
wherea
rvg
protein
observ
pegprecipit
purifi
pegprecipit
purifi
fig
bhkp
cell
respect
infect
recombin
virus
moi
incub
day
titer
determin
day
day
inocul
repres
day
fig
growth
properti
recombin
virus
differ
significantli
titer
reach
peak
day
maintain
level
day
maximum
titer
ffuml
evalu
pathogen
recombin
virus
suckl
mice
intracerebr
inocul
rhep
clinic
sign
monitor
mice
inocul
show
rabiesassoci
sign
surviv
observ
period
fig
hand
seven
suckl
mice
inocul
ffu
rhep
show
sick
postinocul
two
mice
die
postinocul
meet
criteria
euthanasia
rabiesassoci
neurolog
diseas
mice
sacrif
immedi
reach
moribund
stage
day
signific
differ
surviv
rate
observ
mice
inocul
rhep
suggest
also
remain
nonpathogen
mice
evalu
immunogen
recombin
virus
mice
inocul
twice
twice
pb
fig
titer
vna
merscov
rv
determin
use
sera
mice
fig
although
vna
titer
merscov
sera
mice
inocul
twice
sera
mice
inocul
detect
addit
vna
titer
three
mice
inocul
one
mous
inocul
twice
pb
reach
dilut
suggest
titer
background
signific
differ
titer
found
mice
inocul
twice
four
group
fig
hand
vna
titer
rv
iu
sera
almost
mice
inocul
moreov
median
vna
titer
reach
iu
rang
iu
iu
rang
iu
sera
mice
inocul
twice
respect
iu
rang
iu
iu
rang
iu
inocul
twice
respect
wherea
vna
titer
sera
mice
inocul
pb
remain
iu
signific
differ
found
mice
inocul
pb
wherea
signific
differ
observ
vna
titer
rv
among
mous
group
inocul
fig
studi
recombin
pgenedefici
rv
express
merscov
protein
gener
bivalentvaccin
candid
merscov
rv
intraperiton
inocul
mice
twice
elicit
vna
merscov
rv
result
suggest
merscov
vector
system
potenti
immunogen
merscov
well
rv
addit
vaccin
candid
kill
suckl
mice
even
inocul
intracerebr
therebi
exhibit
complet
safeti
profil
accord
vivo
assay
sever
vaccin
platform
merscov
display
immunogen
efficaci
safeti
anim
experi
vaccin
platform
recombin
viral
vector
consid
among
promis
date
viral
vector
util
modifi
vaccinia
viru
ankara
measl
viru
adenoviru
use
express
merscov
glycoprotein
shown
immunogen
accord
vivo
assay
addit
recombin
viral
vector
rv
vector
also
promis
recombin
rv
express
variou
foreign
antigen
elicit
protect
immun
correspond
pathogen
merscov
human
immunodefici
viru
type
ebola
viru
sever
acut
respiratori
syndrom
sar
cov
hepat
c
viru
previou
studi
demonstr
neutral
mab
significantli
reduc
viru
titer
lung
mice
infect
merscov
target
rbd
spike
protein
indic
vna
could
play
import
role
protect
mice
merscov
infect
anoth
report
inactiv
replicationcompet
recombin
rv
express
merscov
protein
elicit
vna
protect
mice
merscov
challeng
present
studi
induc
neutral
activ
merscov
mice
inocul
induct
protect
immun
mice
merscov
infect
follow
immun
suggest
potenti
efficaci
mammal
includ
human
evalu
efficaci
vaccin
develop
merscov
variou
experiment
anim
rang
small
anim
nonhuman
primat
use
challeng
test
present
studi
investig
antibodyinduc
capac
mice
howev
animalchalleng
test
requir
evalu
whether
induc
protect
immun
merscov
whomand
vna
level
rv
iuml
wide
use
indic
adequ
vaccin
present
studi
induc
significantli
hightit
vna
rv
given
correl
vna
protect
expect
vaccin
candid
confer
protect
rv
gener
viral
vector
highli
effect
howev
exist
possibl
safeti
concern
respect
replicationdefici
recombin
rvbase
vector
highli
advantag
given
vaccin
complet
nonpathogen
anim
due
inabl
replic
infect
host
moreov
vaccin
caus
diseas
suckl
mice
suggest
safeti
vaccin
candid
delet
gene
encod
p
protein
genom
preclud
possibl
revers
virul
viru
characterist
replicationdefici
vaccin
candid
promot
efficaci
use
live
vaccin
previou
studi
report
avirul
replicationdefici
rv
viru
express
ebola
viru
glycoprotein
accord
surviv
adult
suckl
mice
intracerebr
inocul
viru
along
mainten
intact
brain
architectur
contrast
replicationcompet
ebola
viru
glycoproteinexpress
rv
vaccin
recov
sad
rv
wildlif
vaccin
strain
harbor
attenu
point
mutat
retain
neurovirul
suckl
mice
administ
intracerebr
studi
merscov
subunit
express
construct
translat
togeth
rvg
transmembran
cytoplasm
domain
amino
acid
ectodomain
rvg
sever
reason
use
construct
first
weak
capac
transcript
replic
pdefici
rv
vector
cell
expect
fulllength
gene
kb
long
express
use
vector
fact
found
recombin
viru
contain
gene
merscov
delet
ctermin
amino
acid
rescu
express
protein
variabl
delet
gene
genom
fig
presum
suggest
fragment
larg
insert
vector
second
transmembran
cytoplasm
domain
rvg
fuse
protein
region
play
import
role
express
foreign
protein
surfac
virion
interestingli
appear
loss
protein
purif
sucros
gradient
compar
pegprecipit
virus
fig
nevertheless
fuse
transmembran
cytoplasm
domain
rv
surfac
express
presum
specif
protein
might
produc
cell
line
might
incorpor
onto
surfac
partial
origin
rvg
protein
would
easier
incorpor
virion
domin
foreign
protein
final
insert
subunit
reportedli
effect
insert
fulllength
gene
develop
dna
vaccin
merscov
case
adenoviru
vectorbas
vaccin
merscov
induc
stronger
vna
respons
express
fulllength
protein
might
immun
subunit
induc
humor
immun
respons
effici
fulllength
protein
addit
might
remain
concern
regard
safeti
use
vaccin
express
fulllength
protein
vaccin
potenti
induc
harm
side
effect
caus
nonneutr
epitop
previou
sarscov
vaccin
studi
report
inflammatori
immunopatholog
effect
eosinophil
infiltr
immun
anim
therefor
insert
subunit
might
favor
antigen
rel
use
fulllength
protein
vaccin
develop
describ
introduct
mer
rabi
result
mani
fatal
case
suggest
diseas
remain
seriou
threat
global
public
health
seroepidemiolog
studi
demonstr
presenc
merscov
dromedari
middl
east
africa
rabi
epidem
occur
consid
epidemiolog
find
bival
vaccin
mer
rabi
would
use
practic
applic
control
situat
conclus
found
intraperiton
vaccin
express
merscov
protein
induc
vna
merscov
rv
mice
suggest
promis
bivalentvaccin
candid
mer
rv
studi
build
upon
previou
work
describ
use
vaccin
lymphocyt
choriomening
viru
support
applic
bivalentvaccin
develop
rabi
infecti
diseas
